Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (681-690 of 1,104) with videos related to

Pageof 111
Sort By:
Clinical and Experimental Otorhinolaryngology|March 31, 2026
Human Papillomavirus (HPV) Infected Epithelial Cells and FBLN1+ Fibroreticular Cells Govern the Immunogenic Tumor Microenvironment in HPV-Associated Oropharyngeal Squamous Cell CarcinomaDoeon Gu, Joonho Shim, Soo Yoon Kim, et al.
Brain Research|March 7, 2008
Involvement of batrachotoxin binding sites in ginsenoside-mediated voltage-gated Na+ channel regulationJun-Ho Lee, Byung-Hwan Lee, Sun-Hye Choi, et al.
Radiation Oncology Journal|March 29, 2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neckSoo-Yoon Sung, Jin Ho Song, Byoung Hyuck Kim, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 7, 2024
Protective effects of Y-27632 against cisplatin-induced ototoxicity: A zebrafish model Y-27632 and cisplatin-induced ototoxicityKang Hyeon Lim, Saemi Park, Eunjung Han, et al.
Kidney International|April 18, 2020
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatmentEric Rondeau, Marie Scully, Gema Ariceta, et al.
Leukemia Research|August 5, 2019
Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemiaSang Mee Hwang, Sung-Min Kim, Youngwon Nam, et al.
European Journal of Medicinal Chemistry|April 28, 2004
Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedioneBok Young Kim, Joong Bok Ahn, Hong Woo Lee, et al.
Molecules and Cells|January 15, 2005
Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodiesSeok Ho Hong, Hee Young Nah, Young Jin Lee, et al.
Radiation Oncology Journal|July 1, 2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer)Yoo-Kang Kwak, Kyung Su Kim, Gyu Sang Yoo, et al.
Journal of Liver Cancer|June 29, 2023
Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinomaAhlim Lee, Jaejun Lee, Hyun Yang, et al.
Pageof 111

Showing results (681-690 of 1,104) with videos related to

Sort By:
Pageof 111
Clinical and Experimental Otorhinolaryngology|March 31, 2026
Human Papillomavirus (HPV) Infected Epithelial Cells and FBLN1+ Fibroreticular Cells Govern the Immunogenic Tumor Microenvironment in HPV-Associated Oropharyngeal Squamous Cell CarcinomaDoeon Gu, Joonho Shim, Soo Yoon Kim, et al.
Brain Research|March 7, 2008
Involvement of batrachotoxin binding sites in ginsenoside-mediated voltage-gated Na+ channel regulationJun-Ho Lee, Byung-Hwan Lee, Sun-Hye Choi, et al.
Radiation Oncology Journal|March 29, 2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neckSoo-Yoon Sung, Jin Ho Song, Byoung Hyuck Kim, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 7, 2024
Protective effects of Y-27632 against cisplatin-induced ototoxicity: A zebrafish model Y-27632 and cisplatin-induced ototoxicityKang Hyeon Lim, Saemi Park, Eunjung Han, et al.
Kidney International|April 18, 2020
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatmentEric Rondeau, Marie Scully, Gema Ariceta, et al.
Leukemia Research|August 5, 2019
Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemiaSang Mee Hwang, Sung-Min Kim, Youngwon Nam, et al.
European Journal of Medicinal Chemistry|April 28, 2004
Synthesis and biological activity of novel substituted pyridines and purines containing 2,4-thiazolidinedioneBok Young Kim, Joong Bok Ahn, Hong Woo Lee, et al.
Molecules and Cells|January 15, 2005
Expression of estrogen receptor-alpha and -beta, glucocorticoid receptor, and progesterone receptor genes in human embryonic stem cells and embryoid bodiesSeok Ho Hong, Hee Young Nah, Young Jin Lee, et al.
Radiation Oncology Journal|July 1, 2024
Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer)Yoo-Kang Kwak, Kyung Su Kim, Gyu Sang Yoo, et al.
Journal of Liver Cancer|June 29, 2023
Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinomaAhlim Lee, Jaejun Lee, Hyun Yang, et al.
Pageof 111